Vantage logo

Darzalex's ambitions extend beyond Maia

Data from quad therapy and a subcutaneous formulation could resuscitate enthusiasm even if the US government shutdown delays Darzalex's upcoming first-line approval.

Vantage logo

The (unsung) best of Ash 2018

A top three of early-stage CAR-T presentations from this year’s Ash meeting that you might have missed.